Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1962 Aug;19(1):85–98. doi: 10.1111/j.1476-5381.1962.tb01429.x

Studies on sympathetic mechanisms in isolated intestinal and vas deferens preparations

G A Bentley
PMCID: PMC1482230  PMID: 13867378

Abstract

The effects of various drugs which block sympathetic nerves have been studied in Finkleman preparations of rabbit and cat ileum. Contractile responses could be produced in many cases after the normal inhibitory responses to periarterial nerve stimulation had been blocked. In almost all cases this contractile response was abolished by ganglion-blocking drugs. The normal rabbit ileum Finkleman preparation was found to behave differently towards bretylium than do preparations taken from animals treated with reserpine. The block of the guinea-pig isolated hypogastric vas deferens preparation caused by hemicholinium HC-3 was found to be reversed in the presence of noradrenaline, histamine, or 5-hydroxytryptamine, as was the block caused by guanethidine and bretylium. The results are discussed in relation to the Burn-Rand theory of sympathetic nerve mechanism.

Full text

PDF
95

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BIRKS R. I., MACINTOSH F. C., SASTRY P. B. Pharmacological inhibition of acetylcholine synthesis. Nature. 1956 Nov 24;178(4543):1181–1181. doi: 10.1038/1781181a0. [DOI] [PubMed] [Google Scholar]
  2. BOURA A. L., COPP F. C., DUNCOMBE W. G., GREEN A. F., McCOUBREY A. The selective accumulation of bretylium in sympathetic ganglia and their postganglionic nerves. Br J Pharmacol Chemother. 1960 Jun;15:265–270. doi: 10.1111/j.1476-5381.1960.tb01242.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BOURA A. L., GREEN A. F. The actions of bretylium: adrenergic neurone blocking and other effects. Br J Pharmacol Chemother. 1959 Dec;14:536–548. doi: 10.1111/j.1476-5381.1959.tb00961.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BURN J. H., RAND M. J. Sympathetic postganglionic cholinergic fibres. Br J Pharmacol Chemother. 1960 Mar;15:56–66. doi: 10.1111/j.1476-5381.1960.tb01210.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BURNSTOCK G., HOLMAN M. E. Spontaneous potential at sympathetic nerve endings in smooth muscle. J Physiol. 1962 Mar;160:446–460. doi: 10.1113/jphysiol.1962.sp006858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CASS R., KUNTZMAN R., BRODIE B. B. Norepinephrine depletion as a possible mechanism of action of guanethidine (SU 5864), a new hypotensive agent. Proc Soc Exp Biol Med. 1960 Apr;103:871–872. doi: 10.3181/00379727-103-25702. [DOI] [PubMed] [Google Scholar]
  7. CHANG V., RAND M. J. Transmission failure in sympathetic nerves produced by hemicholinium. Br J Pharmacol Chemother. 1960 Dec;15:588–600. doi: 10.1111/j.1476-5381.1960.tb00287.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. COSTA E., REVZIN A. M., KUNTZMAN R., SPECTOR S., BRODIE B. B. Role for ganglionic norepinephrine in sympathetic synaptic transmission. Science. 1961 Jun 9;133(3467):1822–1823. doi: 10.1126/science.133.3467.1822. [DOI] [PubMed] [Google Scholar]
  9. DAY M. D., RAND M. J. Effect of guanethidine in revealing cholinergic sympathetic fibres. Br J Pharmacol Chemother. 1961 Oct;17:245–260. doi: 10.1111/j.1476-5381.1961.tb01285.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Finkleman B. On the nature of inhibition in the intestine. J Physiol. 1930 Sep 18;70(2):145–157. doi: 10.1113/jphysiol.1930.sp002683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GARDINER J. E., THOMPSON J. W. Lack of evidence for a cholinergic mechanism in sympathetic transmission. Nature. 1961 Jul 1;191:86–86. doi: 10.1038/191086a0. [DOI] [PubMed] [Google Scholar]
  12. GARRY R. C., WISHART M. Fluid electrodes with a rubber diaphragm. J Physiol. 1951 Dec 28;115(4):61–P. [PubMed] [Google Scholar]
  13. GILLESPIE J. S., MACKENNA B. R. The inhibitory action of the sympathetic nerves on the smooth muscle of the rabbit gut, its reversal by reserpine and restoration by catechol amines and by DOPA. J Physiol. 1961 Apr;156:17–34. doi: 10.1113/jphysiol.1961.sp006655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. MARTIN A. R., ORKAND R. K. Postsynaptic action of HC-3 on neuromuscular transmission. Fed Proc. 1961 Jul;20:579–582. [PubMed] [Google Scholar]
  15. MCCUBBIN J. W., KANEKO Y., PAGE I. H. The peripheral cardiovascular actions of guanethidine in dogs. J Pharmacol Exp Ther. 1961 Mar;131:346–354. [PubMed] [Google Scholar]
  16. THIES R. E., BROOKS V. B. Postsynaptic neuromuscular block produced by hemicholinium no. 3. Fed Proc. 1961 Jul;20:569–578. [PubMed] [Google Scholar]
  17. V Euler U. S., Gaddum J. H. Pseudomotor contractures after degeneration of the facial nerve. J Physiol. 1931 Sep 18;73(1):54–66. doi: 10.1113/jphysiol.1931.sp002796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. WYLIE D. W. Augmentation of the pressor response to guanethedine by inhibition of catechol O-methyltransferase. Nature. 1961 Feb 11;189:490–491. doi: 10.1038/189490a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES